跳至主要内容
临床试验/NCT04226326
NCT04226326已完成不适用

Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion

University of Chicago1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2020年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
4
试验地点
1
主要终点
Change in exercise time on Bruce protocol baseline

研究概览

简要总结

This is prospective cohort study in subjects with a planned percutaneous coronary intervention (PCI) of their chronic total occlusion (CTO). The study will enroll subjects who have been scheduled for a clinically-indicated cardiac catheterization, and will evaluate coronary microvascular function in all subjects meeting inclusion criteria with a coronary flow wire. Evaluation of coronary microvascular function may be performed using indirect methods, however the rationale behind the present study is to directly measure microvascular function using direct coronary flow measurements, since the subjects in the study are to undergo a clinically-indicated cardiac catheterization. The overall purpose of the study is to define the presence and severity of coronary microvascular dysfunction subjects with CTO. The study is designed to enroll 50 subjects with CTO in the span of 3 years. There will be a 6-month assessment of the outcomes of death and cardiovascular death. As the study includes FDA approved tests, there will be no safety endpoint per se, however there will be a mechanism for monitoring adverse events as will be described in detail.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age ≥ 21 years
  • •seen at University of Chicago Medical center with a planned PCI of a single CTO vessel
  • •must have either stable angina or angina equivalent
  • •must have a CTO with a clear donor vessel supplying most of the collaterals.

排除标准

  • •subjects with a pacemaker or implantable cardioverter defibrillator
  • •contraindication to cardiac MRI, adenosine, heparin, or nitroglycerin
  • •cardiac transplantation
  • •Estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/1.73m2, given the risk of contrast-induced nephropathy (CIN) and nephrogenic systemic fibrosis (NSF) associated with iodinated and gadolinium-based contrast agents, respectively, in patients with significant renal dysfunction
  • •Women who may potentially be pregnant will receive a pregnancy test and be excluded if pregnant
  • •Vulnerable populations such as children, college students, prisoners, non-English speakers, and those with diminished decision-making capacity
  • •Inability or refusal to consent for the study.

研究组 & 干预措施

Subjects with Chronic Total Occlusion (CTO)

Other

All subjects in this study have been scheduled for a clinically-indicated cardiac catheterization.

干预措施: Directly measure microvascular function using direct coronary flow measurements (Other)

结局指标

主要结局

Change in exercise time on Bruce protocol baseline

时间窗: 6 months

Change in exercise time from baseline to 6 months post-PCI will be measured. Scale is linear and measured in seconds (can be a negative number), with higher numbers indicating a favorable outcome.

Change in SAQ from baseline to 6 months

时间窗: 6 months

Change in Seattle Angina Questionnaire (SAQ) from baseline to 6 months post-PCI will be measured. Scale is linear and 0-100 units, with higher numbers indicating a favorable outcome.

IMR of opened CTO vessel

时间窗: 6 months

Following CTO PCI, IMR of the opened vessel will be measured. Scale is linear and 1-100 units, higher numbers being worse outcome. 3) Change in SAQ from baseline to 6 months

Baseline myocardial quality of the CTO-supplied vascular bed.

时间窗: Day of procedure

Characterize the microvascular resistance of the donor vessel to 50 CTOs as it relates to vascular bed quality of the CTO-supplied territory. Scaled from 0-102, with 102 being worse than 0. 1. Baseline myocardial quality

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Investigating the Utility of Remote Index of... | 临床试验